Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling

Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling

Pulmonary vascular remodeling, characterized by the thickening of all three layers of the blood vessel wall, plays a central role in the pathogenesis of pulmonary hypertension (PH). Despite the approval of several drugs for PH treatment, their long-term therapeutic effect remains unsatisfactory, as...

Full description

Bibliographic Details
Main Authors:	Qin Fang, Yang Bai, Shuiqing Hu, Jie Ding, Lei Liu, Meiyan Dai, Jie Qiu, Lujin Wu, Xiaoquan Rao, Yan Wang
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Antioxidants
Subjects:	pulmonary vascular remodeling Nrf2 oxidative stress pulmonary hypertension
Online Access:	https://www.mdpi.com/2076-3921/12/11/1978

Similar Items

Pulmonary Vascular Remodeling in Pulmonary Hypertension
by: Zhuangzhuang Jia, et al.
Published: (2023-02-01)

AMPK and Pulmonary Hypertension: Crossroads Between Vasoconstriction and Vascular Remodeling
by: Qiang Zhao, et al.
Published: (2021-06-01)

Effect of overexpression of microRNA-124 on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Zhu Jian, Chen Tiantian, Liu Zhiyong, Zheng Changlong
Published: (2023-08-01)

The effect of rehabilitation exercise on the expression of glutaminase and cardiopulmonary remodeling in pulmonary hypertension
by: Shang Wang, et al.
Published: (2022-09-01)

The effect of transglutaminase-2 inhibitor on pulmonary vascular remodeling in rats with pulmonary arterial hypertension
by: Ting Wang, et al.
Published: (2022-02-01)

Editorial: Pathophysiology and Pathogenic Mechanisms of Pulmonary Vascular Disease
by: Jinsheng Zhu, et al.
Published: (2022-03-01)

Andrographolide Attenuates Established Pulmonary Hypertension via Rescue of Vascular Remodeling
by: Xiaowei Nie, et al.
Published: (2021-11-01)

Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling
by: Shanshan Zhang, et al.
Published: (2020-03-01)

Emerging Epigenetic Targets and Their Molecular Impact on Vascular Remodeling in Pulmonary Hypertension
by: A. Dushani C. U. Ranasinghe, et al.
Published: (2024-01-01)

RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension
by: Lu G, et al.
Published: (2023-10-01)

TNF-α and IL-8 levels are positively correlated with hypobaric hypoxic pulmonary hypertension and pulmonary vascular remodeling in rats
by: Shi Haixia, et al.
Published: (2023-07-01)

Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling
by: Marta T. Gomes, et al.
Published: (2022-02-01)

Serum Liberation of Fetal Fibronectin Variants in Patients with Pulmonary Hypertension: ED-A<sup>+</sup> Fn as Promising Novel Biomarker of Pulmonary Vascular and Right Ventricular Myocardial Remodeling
by: Laura Bäz, et al.
Published: (2021-06-01)

Galectin-3: A potential biomarker in pulmonary arterial hypertension
by: Jie Song, et al.
Published: (2016-01-01)

The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension
by: Vijaya Karoor, et al.
Published: (2021-09-01)

Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension
by: Khushboo Goel, et al.
Published: (2022-12-01)

Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling
by: Rui Wang, et al.
Published: (2022-03-01)

Melatonin Decreases Pulmonary Vascular Remodeling and Oxygen Sensitivity in Pulmonary Hypertensive Newborn Lambs
by: Cristian R. Astorga, et al.
Published: (2018-03-01)

The alveolar epithelial cells are involved in pulmonary vascular remodeling and constriction of hypoxic pulmonary hypertension
by: Yanxia Wang, et al.
Published: (2021-05-01)

Vascular Remodeling in Pulmonary Arterial Hypertension: The Potential Involvement of Innate and Adaptive Immunity
by: Rachid Tobal, et al.
Published: (2021-12-01)

Inhibition of microRNA-30a alleviates vascular remodeling in pulmonary arterial hypertension
by: Wenrui Ma, et al.
Published: (2021-12-01)

Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension
by: Rubin Tan, et al.
Published: (2022-11-01)

HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape
by: Sandra Medrano-Garcia, et al.
Published: (2022-08-01)

Perivascular Inflammation in Pulmonary Arterial Hypertension
by: Yijie Hu, et al.
Published: (2020-10-01)

Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure
by: Wande Yu, et al.
Published: (2022-07-01)

Persistent Pulmonary Hypertension of the Newborn: Pathophysiological Mechanisms and Novel Therapeutic Approaches
by: Sofia Martinho, et al.
Published: (2020-07-01)

Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats
by: Yusheng Cheng, et al.
Published: (2018-08-01)

Hypoxic pulmonary endothelial cells release epidermal growth factor leading to vascular smooth muscle cell arginase‐2 expression and proliferation
by: Bernadette Chen, et al.
Published: (2022-06-01)

Relationship Between Endogenous Hydrogen Sulfide and Pulmonary Vascular Indexes on High-Resolution Computed Tomography in Patients with Chronic Obstructive Pulmonary Disease
by: Liao YX, et al.
Published: (2021-08-01)

ADAR1 regulates vascular remodeling in hypoxic pulmonary hypertension through N1-methyladenosine modification of circCDK17
by: Junting Zhang, et al.
Published: (2023-12-01)

Editorial: Advances in understanding the mechanisms of pulmonary hypertension
by: Ashfaq Ahmad, et al.
Published: (2023-09-01)

Modulation of Pulmonary Vascular Remodeling in Hypoxia: Role of 15-LOX-2/15-HETE-MAPKs Pathway
by: Xiufeng Yu, et al.
Published: (2015-04-01)

The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension
by: Shalina Taylor, et al.
Published: (2018-08-01)

Inactivating the Uninhibited: The Tale of Activins and Inhibins in Pulmonary Arterial Hypertension
by: Gusty Rizky Teguh Ryanto, et al.
Published: (2023-02-01)

CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells
by: Weimin Yu, et al.
Published: (2023-12-01)

Salt-inducible kinase 1 deficiency promotes vascular remodeling in pulmonary arterial hypertension via enhancement of yes-associated protein-mediated proliferation
by: Jiangqin Pu, et al.
Published: (2022-10-01)

Increased Serum Levels of Fetal Tenascin-C Variants in Patients with Pulmonary Hypertension: Novel Biomarkers Reflecting Vascular Remodeling and Right Ventricular Dysfunction?
by: Ilonka Rohm, et al.
Published: (2017-11-01)

Baicalin attenuates pulmonary vascular remodeling by inhibiting calpain-1 mediated endothelial-to-mesenchymal transition
by: He-xi Jiang, et al.
Published: (2023-12-01)

Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling
by: Liu J, et al.
Published: (2024-03-01)

Pulmonary Vascular Remodeling and Prognosis in Patients Evaluated for Heart Transplantation: Insights from the OCTOPUS-CHF Study
by: Jorge Martínez-Solano, et al.
Published: (2022-12-01)